Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
04/03/1996 | EP0703920A1 Myeloid cell leukemia associated gene mcl-1 |
04/03/1996 | EP0703904A1 Pyrimidine cyanoguanidines as k-channel blockers |
04/03/1996 | EP0703897A1 Lipoxin compounds |
04/03/1996 | EP0458861B1 Composition for reparation and prevention of fibrotic lesions |
04/03/1996 | CN1119643A Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their ... |
04/03/1996 | CN1119528A A contraceptive for use by a male |
04/02/1996 | US5504089 Treating urinary incontinence |
04/02/1996 | US5503843 Transdermal delivery of alpha adrenoceptor blocking agents |
04/02/1996 | US5503838 Iodine barrier teat dip |
03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |
03/28/1996 | WO1996009309A1 The oligosaccharide structure of a ligand for e and p selectin |
03/28/1996 | WO1996009051A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
03/28/1996 | WO1996009046A1 5α-REDUCTASE INHIBITORS |
03/28/1996 | WO1996009045A1 Antiestrogenic benzothiophenyl compounds |
03/28/1996 | WO1996009041A1 Benzothiophene compounds, compositions, and methods |
03/28/1996 | WO1996009039A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
03/28/1996 | CA2200449A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
03/28/1996 | CA2200205A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
03/28/1996 | CA2200204A1 Benzothiophene compounds, compositions, and methods |
03/27/1996 | EP0703231A1 2-(4-Hydroxyphenyl)benzothiophene compounds, compositions and methods for alleviating the symptoms of post-menopause syndrome |
03/27/1996 | EP0703228A1 Naphthyl compounds, intermediates, processes, compositions involving them |
03/27/1996 | EP0703221A1 5 alpha-reductase Inhibitors |
03/27/1996 | EP0702961A2 Compositions for minimizing the uterotrophic effect of tamoxifen and its analogs |
03/27/1996 | EP0702555A1 Pyrazolopyrimidinones for the treatment of impotence |
03/27/1996 | EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions |
03/27/1996 | CN1119434A Phenoxyphenylacetic acid derivatives |
03/27/1996 | CN1119189A New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them |
03/27/1996 | CN1119109A Chinese medicine Longyang capsule for tonifying kidney and strengthening yang |
03/26/1996 | US5502046 11β-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents |
03/22/1996 | CA2158591A1 Fatty acid treatment |
03/21/1996 | WO1996008557A1 Human inositol monophosphatase h1 |
03/21/1996 | WO1996008489A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors |
03/21/1996 | WO1996008463A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
03/21/1996 | WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
03/21/1996 | WO1996008228A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
03/21/1996 | DE19534744A1 Neues pharmazeutisches Produkt New pharmaceutical product |
03/21/1996 | CA2199484A1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
03/20/1996 | EP0702013A2 Imidazopyridines |
03/20/1996 | EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists |
03/20/1996 | EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent |
03/20/1996 | EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
03/20/1996 | CN1119014A Benzopyranes as potassium channel openers |
03/20/1996 | CN1119013A Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
03/20/1996 | CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines |
03/20/1996 | CN1031339C Process for preparation of heterocyclically substituted phenylacetic acid derivatives |
03/19/1996 | US5500429 Cardiovascular |
03/19/1996 | US5500222 Mixed with monoglyceride permeation enhancer |
03/19/1996 | CA1338168C Antibiotic ll-e19020 alpha and beta |
03/16/1996 | CA2158225A1 Imidazopyridines |
03/14/1996 | WO1996007658A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
03/14/1996 | WO1996007653A1 Endothelin receptor antagonists |
03/14/1996 | WO1996007426A1 Enteral vaccine for vaginal infections |
03/14/1996 | CA2199255A1 Enteral vaccine for vaginal infections |
03/13/1996 | EP0700905A1 Tricyclic pyrazole derivatives |
03/13/1996 | EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation |
03/13/1996 | EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them |
03/13/1996 | EP0700383A1 Novel 1-phenylalkanone 5-ht 4? receptor ligands |
03/13/1996 | EP0700284A1 Controlled release oxybutynin formulations |
03/13/1996 | CN1118347A Benzotoudened 5-ringneterocycl, preparation and phamaceutical and diagnostic use of same |
03/13/1996 | CA2157998A1 Pharmaceutical compounds |
03/12/1996 | US5498722 Hypotensives |
03/12/1996 | US5498598 Composition for nasal administration of desmopressin |
03/07/1996 | WO1996006937A1 Improvements in production of proteins in host cells |
03/07/1996 | WO1996006845A1 Substituted 9-alkyladenines |
03/07/1996 | WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
03/07/1996 | WO1996006606A1 Dihydro-2,3-benzodiazepine derivatives |
03/07/1996 | CA2198345A1 Improvements in production of proteins in host cells |
03/07/1996 | CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
03/06/1996 | EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
03/06/1996 | EP0699185A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS |
03/06/1996 | EP0699069A1 Endothelin receptor antagonists |
03/06/1996 | CN1117960A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
03/06/1996 | CN1117873A Usage of follicle-stimulating hormone |
03/05/1996 | US5496823 Administering propentofylline or a salt thereof to a patient |
03/05/1996 | US5496807 Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it |
03/05/1996 | US5496802 Protein; antibody |
03/05/1996 | US5496556 Administering a steroid reductase inhibiting compound, an androstene derivative |
02/29/1996 | WO1996005837A1 Use of n-substituted phenothiazines |
02/29/1996 | WO1996005835A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure |
02/29/1996 | WO1996005833A1 Methods of inhibiting endometrial cancer |
02/29/1996 | WO1996005832A1 Methods of inhibiting primary endometrial hyperplasia |
02/29/1996 | DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines |
02/29/1996 | CA2198256A1 Use of n-substituted phenothiazines |
02/29/1996 | CA2198120A1 Methods of inhibiting primary endometrial hyperplasia |
02/29/1996 | CA2198119A1 Methods of inhibiting endometrial cancer |
02/29/1996 | CA2198090A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure |
02/28/1996 | EP0698614A1 Endothelin-antagonizing peptide |
02/28/1996 | EP0698094A1 Bmp-11 compositions |
02/28/1996 | EP0698040A1 Lhrh antagonists |
02/28/1996 | EP0698020A1 Pyrimidine derivatives |
02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
02/28/1996 | EP0697873A1 Olefin-substituted long chain compounds |
02/28/1996 | CN1117484A Fatty acid derivatives |
02/27/1996 | US5494907 11-β substituted-19-nor steroids |
02/27/1996 | US5494670 Method of treating ketosis |
02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
02/22/1996 | WO1996005544A1 Current-to-pressure transducer with selectable, adjustable input filter |
02/22/1996 | WO1996005221A1 Calcitonin receptor |
02/22/1996 | WO1996005216A1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |